CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Clofarabine in combination with a standard remission induction regimen in patients 18-60 years old previously untreated intermediate an bad risk actue myelogenous leukemia (AML) or high risk myelodysplasia (MDS): combined phase I/II results of the EORTC/Gimema AML-14A trial
Author
AMADORI Sergio
BARON Frédéric
+14Â more
BRON Dominique
DE WITTE Theo
HALKES Constantijn J.M.
MARIE Jean-Pierre
MEERT Liv
MELONI Giovanna
MUUS Petra
PRUIJT Hans
RAMADAN Safaa M.
SELLESLAG Dominik L.D.
SUCIU Stefan
VENDITTI Adriano
VIGNETTI Marco
WILLEMZE Roelof
Publication venue
Publication date
01/12/2014
Field of study
Full text link
Open Repository and Bibliography - Liège
Phase 3, Placebo-Controlled, ASPIRE Study (TRC114968) of Eltrombopag (EPAG) Treatment of Thrombocytopenia (TCP) in Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Assessment of Clinical Benefit, Safety, and Tolerability
Author
Achilles Anagnostopoulos
Ana Isabel Rosell Mas
+14Â more
Arnon Nagler
Benjamin Brenner
Boris V Afanasyev
Claudio Denzlinger
Dominik L.D. Selleslag
Frank Mannino
Geoffrey Chan
Giuseppe Rossi
Moshe Mittelman
Nicole L. Stone
Raymond SM Wong
Sebastian Grosicki
Uwe Platzbecker
Yasser Mostafa Kamel
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref